Biolegend, 100712, APC anti-mouse CD8a Antibody, 100μg

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Mouse thymus or spleen
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).
Application References(PubMed link indicates BioLegend citation): Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP) Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete) Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP) Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block) Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC) Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC) Shih FF, et al. 2006. J. Immunol. 176:3438. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete) Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed Lee CH, et al. 2009. Clin. Cancer Res. PubMed Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Medyouf H, et al. 2010. Blood 115:1175. PubMed Riedl P, et al. 2009. J. Immunol. 183:370. PubMed Apte SH, et al. 2010. J. Immunol. 185:998. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Cui L, et al. 2015. J Control Release. 206:220. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed Schuster M, et al. 2017. J Immunol. 199:920. PubMed Li X et al. 2019. Immunity. 50(3):576-590 . PubMed O'Malley G, et al. 2018. Cancer Immunol Res. 1.240277778. PubMed Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed Xu X, et al. 2020. Chin Med. 15:33. PubMed Puth S, et al. 2022. Biomaterials. 286:121542. PubMed Guo A, et al. 2022. Nature. 607:135. PubMed Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed Chen H, et al. 2023. Nat Commun. 14:941. PubMed Li X, et al. 2023. J Clin Invest. 133:. PubMed Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed Saha S, et al. 2023. Sci Rep. 13:4609. PubMed Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed Zhang J, et al. 2023. Theranostics. 13:2226. PubMed Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed He Y, et al. 2023. Biomolecules. 13:. PubMed Deng G, et al. 2023. Cancers (Basel). 15:. PubMed Wang Y, et al. 2023. iScience. 26:106630. PubMed Wang K, et al. 2023. Nat Commun. 14:2950. PubMed Wang D, et al. 2023. Nat Commun. 14:2943. PubMed Li M, et al. 2023. BMC Cancer. 23:497. PubMed Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed Lan Y, et al. 2023. iScience. 26:106817. PubMed Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed Song S, et al. 2023. Bioact Mater. 28:358. PubMed Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed Thomas R, et al. 2021. Immunology. 163:478. PubMed Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed Schenkel JM, et al. 2021. Immunity. 54:2338. PubMed Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed Li X, et al. 2022. J Clin Invest. 132: . PubMed Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed Marié IJ, et al. 2022. Bio Protoc. 12:e4438. PubMed Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed Xie DH, et al. 2022. Med Phys. 49:6728. PubMed Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed Yu J, et al. 2022. Nat Commun. 13:7903. PubMed Morrow RJ, et al. 2022. Cells. 11: . PubMed Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed Ding D, et al. 2023. J Med Chem. 66:1467. PubMed Lin J, et al. 2023. Nat Commun. 14:224. PubMed Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed Ali LR, et al. 2023. J Exp Med. 220: . PubMed Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed Wang R, et al. 2023. NPJ Vaccines. 8:6. PubMed Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed Zheng J, et al. 2023. Biomater Res. 27:9. PubMed Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Ye L, et al. 2022. Cell Metab. 34:595. PubMed Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed Stone VM, et al. 2022. iScience. 25:105070. PubMed Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed Renrick AN, et al. 2021. Front Immunol. 607044:12. PubMed Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed Bian L, et al. 2022. Front Immunol. 13:938598. PubMed Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed Jiang Q, et al. 2022. Theranostics. 12:59. PubMed Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed Iwasaki Y, et al. 2016. PLoS One. 11: 0158282. PubMed Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed Dong L, et al. 2021. Cancer Cell. . PubMed Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed Wang D, et al. 2018. Immunity. 48:659. PubMed Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed Song C, et al. 2019. Nat Commun. 10:3745. PubMed Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed Li ZX, et al. 2022. Arch Virol. :. PubMed Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed Bauer KM, et al. 2022. JCI Insight. 7:. PubMed Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed Tian H, et al. 2022. Cancer Sci. 113:875. PubMed Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed He C, et al. 2020. Clin Transl Med. 10:e39. PubMed Pan H, et al. 2020. Mol Psychiatry. . PubMed Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed Lee JH, et al. 2018. Transgenic Res. 27:241. PubMed Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed Yin Y, et al. 2021. ACS Nano. 15:14347. PubMed Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed Lebratti T, et al. 2021. eLife. 10:00. PubMed Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed Shade K, et al. 2015. J Exp Med. 212:457. PubMed Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed Li Y, et al. 2019. Oncol Rep. 41:2679. PubMed Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed Frey N, et al. 2022. Nat Commun. 13:1804. PubMed Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed Zhan Y, et al. 2021. JCI Insight. 6:. PubMed Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed Vieyra-Garcia P, et al. 2016. Clin Cancer Res. 22: 3328 - 3339. PubMed Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed Solanki A, et al. 2018. Development. 145. PubMed Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed Zhang F, et al. 2019. Immunity. 50:738. PubMed Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed Huang Y, et al. 2020. FASEB J. 34:1768. PubMed Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed Brummer G, et al. 2020. Oncogene. 39:2275. PubMed Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed Liu J, et al. 2019. J Exp Med. 216:656. PubMed Funk KE, et al. 2019. J Neuroinflammation. 16:22. PubMed Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed Divan A, et al. 2018. PLoS One. 13:e0196893. PubMed He X, et al. 2021. Small. 17:e2007165. PubMed Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed Katsinas N, et al. 2022. J Clin Med. 11:. PubMed He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed Hoefflin R, et al. 2020. Nat Commun. 3.313194444. PubMed Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed Zheng Z, et al. 2020. Cell Death Dis. 0.684722222. PubMed Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed Li W, et al. 2019. Nat Commun. 10:3349. PubMed Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed Liu T, et al. 2022. Front Immunol. 13:901349. PubMed Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed Gibbins J, et al. 2014. Blood. 124:2953. PubMed Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed Cook KD, et al. 2015. Immunity. 43:703-714. PubMed Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed Matsuo K, et al. 2018. J Immunol. 200:800. PubMed Takaku S, et al. 2020. Integr Cancer Ther. 19:1534735419900798. PubMed Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed Medyouf H, et al. 2010. Blood. 115:1175. PubMed Oka Y, et al. 2020. Sci Adv. 6:. PubMed Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed Li H, et al. 2021. Nat Commun. 12:7149. PubMed Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed Shen M, et al. 2022. Nat Cancer. 3:60. PubMed Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed Li YN, et al. 2022. Nat Commun. 13:4074. PubMed Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed Lin W, et al. 2019. EBioMedicine. 49:133. PubMed Chen Z, et al. 2019. J Exp Med. 216:152. PubMed Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed Ding P, et al. 2022. Bone Res. 10:42. PubMed Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed Sun S, et al. 2013. J Immunol. 190:6209. PubMed Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed Nanou A, et al. 2021. Cell Reports. 35(8):109168. PubMed Lin YH, et al. 2018. Cancer Immunol Res. 0.25. PubMed Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed Nahrendorf W, et al. 2021. eLife. 10:00. PubMed Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed Wu L, et al. 2020. Cell Rep. 33:108327. PubMed Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed Takahashi F, et al. 2022. iScience. 25:104278. PubMed Qi J, et al. 2021. Nat Commun. 12:4755. PubMed Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed Li X, et al. 2021. Cell Death Dis. 12:314. PubMed Frazer GL, et al. 2021. J Cell Biol. 220:. PubMed Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed Zhao X, et al. 2022. iScience. 25:104690. PubMed Huber MK, et al. 2021. J Vis Exp. :. PubMed Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed Li X, et al. 2017. Front Immunol. 8:1186. PubMed Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed Fonderflick L, et al. 2022. Cells. 11:. PubMed Rao L, et al. 2020. Nat Commun. 11:4909. PubMed Murata T, et al. 2020. Sci Rep. 10:13560. PubMed He X, et al. 2021. J Immunother Cancer. 9:. PubMed Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed Tassi I, et al. 2014. J Immunol. 193:4303. PubMed Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed Yin X, et al. 2020. Cell Rep. 33:108278. PubMed Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed Zhang Z, et al. 2020. Nature. 579:415. PubMed Harrison DK, et al. 2021. Transplantation. 105:540. PubMed Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed Liu YW, et al. 2022. JCI Insight. 7:. PubMed Sun Y, et al. 2022. iScience. 25:104846. PubMed Chen B, et al. 2021. Cell. 184:6262. PubMed Smith LK, et al. 2021. Elife. 10:. PubMed Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed Konishi Y, et al. 2018. iScience. 10:98. PubMed Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed Zheng Y, et al. 2022. Transl Res. :. PubMed Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed Bessell CA, et al. 2020. JCI Insight. 5:. PubMed Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed Li X, et al. 2021. Front Immunol. 12:779560. PubMed
RRID: AB_312750 (BioLegend Cat. No. 100711) AB_312751 (BioLegend Cat. No. 100712)
Structure: Ig superfamily, CD8α chain, 34 kD
Distribution: Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells
Function: Co-receptor for TCR
Ligand/Receptor: MHC class I molecule
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Zamoyska R. 1994. Immunity 1:243. 3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.
Gene ID: 12525
UniProt: View information about CD8alpha on UniProt.org
Clone: 53-6.7
Regulatory Status: RUO
Other Names: T8, Lyt2, Ly-2
Isotype: Rat IgG2a, κ